BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, Heckel A, Rettig WJ.
Tuesday, August 19, 2008
Angiokinase - Boehringer Ingelheim
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment